Normalized wall thickness at MRE predicts clinical remission in Crohn's disease after infliximab discontinuation: a 5 years follow-up

被引:4
|
作者
Annunziata, M. L. [1 ]
Papparella, L. G. [1 ]
Sansoni, I. [2 ]
Balestrieri, P. [1 ]
Cicala, M. [1 ]
机构
[1] Campus Bio Med, Gastroenterol, Rome, Italy
[2] Campus Bio Med, Radiol, Rome, Italy
来源
关键词
D O I
10.1016/S1873-9946(14)60522-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P402
引用
收藏
页码:S233 / S233
页数:1
相关论文
共 50 条
  • [41] Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up
    De Greef, Elisabeth
    Hoffman, Ilse
    Smets, Francoise
    Van Biervliet, Stephanie
    Bontems, Patrick
    Hauser, Bruno
    Paquot, Isabelle
    Alliet, Philippe
    Arts, Wim
    Dewit, Olivier
    De Vos, Martine
    Baert, Filip
    Bossuyt, Peter
    Rahier, Jean-Francois
    Franchimont, Denis
    Vermeire, Severine
    Fontaine, Fernand
    Louis, Edouard
    Coche, J. C.
    Veereman, Gigi
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 63 (02): : 253 - 258
  • [42] Infliximab in clinical routine: experience with Crohn's disease and biomarkers of inflammation over 5 years
    Lonnkvist, Maria H.
    Befrits, Ragnar
    Lundberg, Jon O.
    Lundahl, Joachim
    Fagerberg, Ulrika L.
    Hjortswang, Henrik
    van Hage, Marianne
    Hellstrom, Per M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (10) : 1168 - 1176
  • [43] Malignancy in Patients with Crohn's Disease: Data from the TREAT™ Registry with More Than 5 Years of Follow-up
    Lichenstein, G.
    Feagan, Brian
    Cohen, R.
    Salzberg, B.
    Diamond, R.
    Langholff, W.
    Londhe, A.
    Sandborn, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S408 - S409
  • [44] Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
    Lichtenstein, Gary R.
    Feagan, Brian G.
    Cohen, Russell D.
    Salzberg, Bruce A.
    Diamond, Robert H.
    Price, Samiyeh
    Langholff, Wayne
    Londhe, Anil
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (09): : 1409 - 1422
  • [45] Safety of infliximab and other Crohn's disease therapies:: Treat™ registry data with 24,575 patient-years of follow-up
    Lichtenstein, Gary
    Cohen, R.
    Feagan, B.
    Sandborn, W.
    Salzberg, B.
    Chen, D.
    Turner, M.
    Mink, D.
    Broussard, D.
    Diamond, R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S436 - S436
  • [46] PAGETS-DISEASE 5 YEARS FOLLOW-UP AFTER PAMIDRONATE THERAPY
    RYAN, PJ
    FOGELMAN, I
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (01): : 98 - 99
  • [47] Intestinal Transplantation for Crohn's Disease: A 5-Year Nationwide Follow-Up
    Limketkai, Berkeley N.
    Orandi, Babak
    Luo, Xun
    Colombel, Jean-Frederic
    Segev, Dorry L.
    GASTROENTEROLOGY, 2015, 148 (04) : S241 - S241
  • [48] Controlled trial of antituberculous chemotherapy in Crohn's disease - A 5 year follow-up
    Thomas, GAO
    Swift, GL
    Green, J
    Newcombe, RG
    Rhodes, J
    Wilkinson, S
    Stohmeyer, G
    Kruezpainter, G
    GUT, 1997, 41 : A224 - A224
  • [49] Clinical patterns of Crohn's disease in Greece: A follow-up study of 155 cases
    Triantafillidis, JK
    Emmanouilidis, A
    Manousos, O
    Nicolakis, D
    Kogevinas, M
    DIGESTION, 2000, 61 (02) : 121 - 128
  • [50] Austrian infliximab experience in Crohn's disease: a nationwide cooperative study with long-term follow-up
    Wenzl, HH
    Reinisch, W
    Jahnel, J
    Stockenhuber, F
    Tilg, H
    Kirchgatterer, A
    Petritsch, W
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (08) : 767 - 773